MARINA OMAROV: Open Payments
NPI 1316369234 · HALLANDALE BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,401 in 29 payments from 14 companies in 2025. Trend: 2023 $191 · 2024 $1,811 · 2025 $1,401
Food & beverage: $1,401
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 5 | $612 |
| Janssen Biotech, Inc. | 7 | $248 |
| Incyte Corporation | 1 | $138 |
| Regeneron Healthcare Solutions, Inc. | 3 | $79 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $73 |
| UCB, Inc. | 1 | $36 |
| Lilly USA, LLC | 1 | $35 |
| Organon LLC | 2 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| Botanix SB Inc | 1 | $27 |
Products named: NEMLUVIO, TREMFYA, Opzelura, ILUMYA, DUPIXENT, Bimzelx, TALTZ, VTAMA.
Industry payments across FL — which companies pay providers there.
